Nyambe H, Santoso A, Tabri NA, Iskandar H, Ilyas M, Wiriyansyah EP. The survival rate comparison of non small cell lung carcinoma patients who are given by epidermal growth factor receptor-tyrosin kinase inhibitor and those given by first-line chemotherapy treatment. NMSJ [Internet]. 2022 Jan. 20 [cited 2024 Dec. 4];6(2):103-15. Available from: https://journal.unhas.ac.id/index.php/jmednus/article/view/18857